Alzheimer's researcher evaluating scans

The Pacific Alzheimer Research Foundation

The Pacific Alzheimer Research Foundation (PARF) was incorporated in 2004 under the BC Society Act. It is based in British Columbia, Canada and focuses exclusively on funding scientific research and investigation into the cause, prevention and treatment of Alzheimer’s disease and related dementias.

In 2006, PARF received a $15 million grant from the BC government to support scientific research undertaken by qualified scientific investigators and researchers in BC. This endowment has been supplemented by private donations.

Alzheimer’s disease is devastating to its victims and their families, and has a profoundly negative impact on Canadian society. The economic burden of Alzheimer’s disease in the billions of dollars, with incalculable costs to quality of life for patients and their families. There are tens of thousands new cases of Alzheimer’s disease diagnosed in Canada each year and the number is continuing to grow.

PARF initially provided its support independently through peer-reviewed grants to qualified scientific researchers. Subsequently, in an effort to leverage its funding and to direct its funding to the highest quality scientific research, PARF has entered into collaborative partnership arrangements with other organizations that fund compatible scientific research programs under rigorous and established peer review principles. These additional organizations include the Alzheimer Society of Canada, the Michael Smith Foundation for Health Research, Brain Canada, and Genome British Columbia.

The Pacific Alzheimer Research Foundation is registered as a Charitable Society under the Societies Act of British Columbia, with Revenue Canada Charitable Registration # 85798-7978-RR0001.

Our Research Projects

Governance and Guiding Principles

CONSTITUTION

The purposes of the Foundation are:

  1. To undertake fund raising activities for the continuous and long terms support of research, to be undertaken by qualified scientific investigators in Canada, into the cause, prevention and treatment of Alzheimer’s disease and other neurodegenerative dementias.
  2. To obtain funds in the form of monies or other properties, and to distribute funds to qualified scientific investigators in accordance with the Foundation’s objectives.

The Foundation shall be operated exclusively for charitable purposes without financial gain to its members. All profits and other accretions to the assets of the Foundation shall be used to promote its purposes as set forth in paragraph 2. No part of any income of the Foundation shall be payable or otherwise available for the personal benefit of the members. This provision is unalterable.

Our Directors
Our Partners